Decentralized or hybrid trial models have not been widely adopted in clinical research until now. See how COVID-19 is ushering in a new era of clinical research.

Download this white paper to explore:

  • The far-reaching effects of COVID-19 on the clinical research industry
  • Increased enrollment and retention through decentralized/hybrid trial models
  • Keeping trials on track through innovative technological solutions


When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us